Adaptive Biotechnologies Hits Day High with 9.72% Surge in Stock Price

Adaptive Biotechnologies Corp. has experienced a significant uptick in its stock performance, gaining 9.72% on June 11, 2026. The stock reached an intraday high of USD 19.29, reflecting strong market activity. This small-cap company, operating within the Pharmaceuticals & Biotechnology sector, has shown impressive performance metrics over various time frames. In the past year, Adaptive Biotechnologies has delivered a remarkable return of 76.2%, significantly outperforming the S&P 500, which posted a return of 22.78% during the same period. The company has also demonstrated consistent growth, with a 38.33% increase over the past month and a 3.6% rise over the past week. Financially, Adaptive Biotechnologies reported a notable operating profit growth of 91.28% and has achieved positive results for eight consecutive quarters. The company’s net sales for the first half of the year reached USD 142.56 million, marking a growth of 42.69%. Despite some risks associated with its trading position, the stock's high institutional holdings at 100% indicate a robust backing from investors with substantial analytical resources.